Evaluation of 5-HT7 receptor antagonism for the treatment of anxiety, depression, and schizophrenia through the use of receptor-deficient mice

[1]  W. Qin,et al.  Abnormal Resting-State Functional Connectivity in the Whole Brain in Lifelong Premature Ejaculation Patients Based on Machine Learning Approach , 2019, Front. Neurosci..

[2]  Xia Li,et al.  Effects of 5-HT7 receptor antagonists on behaviors of mice that detect drugs used in the treatment of anxiety, depression, or schizophrenia , 2019, Behavioural Brain Research.

[3]  E. Lacivita,et al.  The brain-penetrant 5-HT7 receptor agonist LP-211 reduces the sensory and affective components of neuropathic pain , 2017, Neurobiology of Disease.

[4]  R. Jaeschke,et al.  Vortioxetine: A review of the pharmacology and clinical profile of the novel antidepressant , 2017, Pharmacological reports : PR.

[5]  M. Didriksen,et al.  Asenapine modulates mood‐related behaviors and 5‐HT1A/7 receptors‐mediated neurotransmission , 2017, CNS neuroscience & therapeutics.

[6]  C. Papatheodoropoulos,et al.  Effects of 5-HT-7 receptor ligands on memory and cognition , 2016, Neurobiology of Learning and Memory.

[7]  R. Jaeschke,et al.  Lurasidone: The 2016 update on the pharmacology, efficacy and safety profile , 2016, Pharmacological reports : PR.

[8]  I. Okun,et al.  AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders , 2016, Journal of Alzheimer's disease : JAD.

[9]  G. Kronenberg,et al.  The serotonergic system in the neurobiology of depression: Relevance for novel antidepressants , 2016, Journal of psychopharmacology.

[10]  Jung-Ae Kim,et al.  Up-regulation of cathepsin S expression by HSP90 and 5-HT7 receptor-dependent serotonin signaling correlates with triple negativity of human breast cancer , 2016, Breast Cancer Research and Treatment.

[11]  P. Svenningsson,et al.  S100B interacts with the serotonin 5-HT7 receptor to regulate a depressive-like behavior , 2015, European Neuropsychopharmacology.

[12]  M. Blachuta,et al.  Antidepressant- and Anxiolytic-Like Effects of New Dual 5-HT1A and 5-HT7 Antagonists in Animal Models , 2015, PloS one.

[13]  A. Roberts,et al.  The 5-HT7 receptor as a potential target for treating drug and alcohol abuse , 2015, Front. Neurosci..

[14]  A. Roberts,et al.  The 5-HT 7 receptor as a potential target for treating drug and alcohol abuse , 2015 .

[15]  J. Terrón,et al.  Novel insights into the potential involvement of 5-HT7 receptors in endocrine dysregulation in stress-related disorders , 2014, Reviews in the neurosciences.

[16]  A. Gasbarri,et al.  Serotonergic 5-HT7 receptors and cognition , 2014, Reviews in the neurosciences.

[17]  W. Khan,et al.  Targeted Inhibition of Serotonin Type 7 (5-HT7) Receptor Function Modulates Immune Responses and Reduces the Severity of Intestinal Inflammation , 2013, The Journal of Immunology.

[18]  Oliver Stiedl,et al.  5-HT1A and 5-HT7 receptor crosstalk in the regulation of emotional memory: Implications for effects of selective serotonin reuptake inhibitors , 2012, Neuropharmacology.

[19]  A. Roberts,et al.  The 5‐HT7 receptor in learning and memory , 2012, Hippocampus.

[20]  V. Pérez,et al.  A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder , 2011, The international journal of neuropsychopharmacology.

[21]  A. Roberts,et al.  The 5-HT7 receptor as a mediator and modulator of antidepressant-like behavior , 2010, Behavioural Brain Research.

[22]  O. Mnie-Filali,et al.  Therapeutic potential of 5-HT7 receptors in mood disorders. , 2009, Current drug targets.

[23]  P. Hedlund,et al.  The 5-HT7 receptor is involved in allocentric spatial memory information processing , 2009, Behavioural Brain Research.

[24]  P. Hedlund.  The 5-HT7 receptor and disorders of the nervous system: an overview , 2009, Psychopharmacology.

[25]  Bryan L. Roth,et al.  Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo , 2009, Psychopharmacology.

[26]  P. Svenningsson,et al.  5-HT7 receptor stimulation by 8-OH-DPAT counteracts the impairing effect of 5-HT(1A) receptor stimulation on contextual learning in mice. , 2008, European journal of pharmacology.

[27]  P. Bonaventure,et al.  Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity , 2008, Behavioural pharmacology.

[28]  M. Geyer,et al.  Inactivation of the 5-HT7 Receptor Partially Blocks Phencyclidine-Induced Disruption of Prepulse Inhibition , 2008, Biological Psychiatry.

[29]  M. Geyer,et al.  Inactivation of the 5-HT7 receptor partially blocks PCP-induced disruption of prepulse inhibition , 2008 .

[30]  J. Witkin,et al.  Constitutive deletion of the serotonin-7 (5-HT7) receptor decreases electrical and chemical seizure thresholds , 2007, Epilepsy Research.

[31]  P. Bonaventure,et al.  Selective Blockade of 5-Hydroxytryptamine (5-HT)7 Receptors Enhances 5-HT Transmission, Antidepressant-Like Behavior, and Rapid Eye Movement Sleep Suppression Induced by Citalopram in Rodents , 2007, Journal of Pharmacology and Experimental Therapeutics.

[32]  A. Wesołowska,et al.  Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats. , 2006, European journal of pharmacology.

[33]  J. Mazurkiewicz,et al.  Risperidone Irreversibly Binds to and Inactivates the h5-HT7 Serotonin Receptor , 2006, Molecular Pharmacology.

[34]  Xia Li,et al.  Metabotropic Glutamate 5 Receptor Antagonism Is Associated with Antidepressant-Like Effects in Mice , 2006, Journal of Pharmacology and Experimental Therapeutics.

[35]  A. Wesołowska,et al.  Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression , 2006, Neuropharmacology.

[36]  R. Hen,et al.  Recent advances in animal models of chronic antidepressant effects: The novelty-induced hypophagia test , 2005, Neuroscience & Biobehavioral Reviews.

[37]  S. Henriksen,et al.  5-HT7 Receptor Inhibition and Inactivation Induce Antidepressantlike Behavior and Sleep Pattern , 2005, Biological Psychiatry.

[38]  D. McKinzie,et al.  Pharmacological characterization of stress-induced hyperthermia in DBA/2 mice using metabotropic and ionotropic glutamate receptor ligands , 2005, Psychopharmacology.

[39]  P. Whiting,et al.  Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression , 2005, Neuropharmacology.

[40]  J. Sutcliffe,et al.  Functional, molecular and pharmacological advances in 5-HT7 receptor research. , 2004, Trends in pharmacological sciences.

[41]  J. Sutcliffe,et al.  Mice lacking 5‐HT7 receptors show specific impairments in contextual learning , 2004, The European journal of neuroscience.

[42]  Xia Li,et al.  A rapid punishment procedure for detection of anxiolytic compounds in mice , 2004, Psychopharmacology.

[43]  L. Dinardo,et al.  Midbrain Raphe Modulation of Nonphotic Circadian Clock Resetting and 5-HT Release in the Mammalian Suprachiasmatic Nucleus , 2003, The Journal of Neuroscience.

[44]  R. Glennon.  Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7). , 2003, Journal of medicinal chemistry.

[45]  J. Sutcliffe,et al.  No hypothermic response to serotonin in 5-HT7 receptor knockout mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[46]  D. Treit,et al.  Dorsal and ventral hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests , 2002, Brain Research.

[47]  M. Didriksen,et al.  Effects of the 5-HT7 receptor antagonist SB-258741 in animal models for schizophrenia , 2002, Pharmacology Biochemistry and Behavior.

[48]  M. Didriksen,et al.  Effects of the 5-HT6 receptor antagonist, SB-271046, in animal models for schizophrenia , 2002, Pharmacology Biochemistry and Behavior.

[49]  J. Hagan,et al.  Characterization of SB‐269970‐A, a selective 5‐HT7 receptor antagonist , 2000, British journal of pharmacology.

[50]  A. Eison,et al.  Effects of Antidepressants on 5-HT7 Receptor Regulation in the Rat Hypothalamus , 1999, Neuropsychopharmacology.

[51]  R. Nelson,et al.  Behavior in Mice with Targeted Disruption of Single Genes , 1998, Neuroscience & Biobehavioral Reviews.

[52]  T. Branchek,et al.  Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. , 1993, The Journal of biological chemistry.

[53]  J. Schwartz,et al.  Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[54]  M. Erlander,et al.  A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms , 1993, Neuron.

[55]  D. Sibley,et al.  Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. , 1993, The Journal of biological chemistry.

[56]  R. Porsolt,et al.  Depression: a new animal model sensitive to antidepressant treatments , 1977, Nature.